Pharmaceutical Pricing and Reimbursement Policies in Canada [E-Book] / Valérie Paris and Elizabeth Docteur
This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of objectives re...
Saved in:
Full text |
|
Personal Name(s): | Paris, Valérie. |
Docteur, Elizabeth. | |
Imprint: |
Paris :
OECD Publishing,
2006
|
Physical Description: |
91 p. ; 21 x 29.7cm. |
Note: |
englisch |
DOI: |
10.1787/346071162287 |
Series Title: |
/* Depending on the record driver, $field may either be an array with
"name" and "number" keys or a flat string containing only the series
name. We should account for both cases to maximize compatibility. */?>
OECD Health Working Papers ;
24 |
Keywords: |
Social Issues/Migration/Health Canada |
This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of objectives relating to the pharmaceutical policy. The federal government regulates prices of patented pharmaceutical products with the objective of protecting consumers against excessive prices. Regulation has very likely been responsible for bringing Canada’s prices for patented medicines roughly in line with European comparators. Prices of generic products, which are not regulated, are relatively high although high... |